APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Favipiravir Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Favipiravir Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173991040323 December 2025182 pages

Choose your research edition.

Industry ResearchFavipiravir Tablets Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Favipiravir Tablets Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Favipiravir Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Favipiravir Tablets Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Favipiravir Tablets Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Favipiravir Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Favipiravir Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Favipiravir Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Favipiravir Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Favipiravir Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Favipiravir Tablets include Sun Pharma, Hisun Pharm, R-Pharma, Lupin, Glenmark, Fujifilm, Dr. Reddy, Cipla and ChemRar Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Favipiravir Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Favipiravir Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Favipiravir Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Favipiravir Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Favipiravir Tablets Segment by Company

Sun Pharma

Hisun Pharm

R-Pharma

Lupin

Glenmark

Fujifilm

Dr. Reddy

Cipla

ChemRar Group

Favipiravir Tablets Segment by Type

Brand Drug

Generic Drug

Favipiravir Tablets Segment by Application

Influenza Viruses

COVID-19

Others

Favipiravir Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Favipiravir Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Favipiravir Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Favipiravir Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Favipiravir Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Favipiravir Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Favipiravir Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Favipiravir Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Favipiravir Tablets Industry Trends Table 2. Favipiravir Tablets Industry Drivers Table 3. Favipiravir Tablets Industry Opportunities and Challenges Table 4. Favipiravir Tablets Industry Restraints Table 5. Global Favipiravir Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Favipiravir Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Favipiravir Tablets Sales by Manufacturers (k pcs) & (2021-2026) Table 8. Global Favipiravir Tablets Sales Market Share by Manufacturers Table 9. Global Favipiravir Tablets Average Sales Price (USD/pcs) of Manufacturers (2021-2026) Table 10. Global Favipiravir Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Favipiravir Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Favipiravir Tablets Manufacturers, Product Type & Application Table 13. Global Favipiravir Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Favipiravir Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Brand Drug Table 17. Major Manufacturers of Generic Drug Table 18. Global Favipiravir Tablets Sales by Type 2021 VS 2025 VS 2032 (k pcs) Table 19. Global Favipiravir Tablets Sales by Type (2021-2026) & (k pcs) Table 20. Global Favipiravir Tablets Sales by Type (2027-2032) & (k pcs) Table 21. Global Favipiravir Tablets Sales Market Share by Type (2021-2026) Table 22. Global Favipiravir Tablets Sales Market Share by Type (2027-2032) Table 23. Global Favipiravir Tablets Revenue by Type 2021 VS 2025 VS 2032 (k pcs) Table 24. Global Favipiravir Tablets Revenue by Type (2021-2026) & (k pcs) Table 25. Global Favipiravir Tablets Revenue by Type (2027-2032) & (k pcs) Table 26. Global Favipiravir Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Favipiravir Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Influenza Viruses Table 29. Major Manufacturers of COVID-19 Table 30. Major Manufacturers of Others Table 31. Global Favipiravir Tablets Sales by Application 2021 VS 2025 VS 2032 (k pcs) Table 32. Global Favipiravir Tablets Sales by Application (2021-2026) & (k pcs) Table 33. Global Favipiravir Tablets Sales by Application (2027-2032) & (k pcs) Table 34. Global Favipiravir Tablets Sales Market Share by Application (2021-2026) Table 35. Global Favipiravir Tablets Sales Market Share by Application (2027-2032) Table 36. Global Favipiravir Tablets Revenue by Application 2021 VS 2025 VS 2032 (k pcs) Table 37. Global Favipiravir Tablets Revenue by Application (2021-2026) & (k pcs) Table 38. Global Favipiravir Tablets Revenue by Application (2027-2032) & (k pcs) Table 39. Global Favipiravir Tablets Revenue Market Share by Application (2021-2026) Table 40. Global Favipiravir Tablets Revenue Market Share by Application (2027-2032) Table 41. Global Favipiravir Tablets Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Table 42. Global Favipiravir Tablets Sales by Region (2021-2026) & (k pcs) Table 43. Global Favipiravir Tablets Sales Market Share by Region (2021-2026) Table 44. Global Favipiravir Tablets Sales Forecasted by Region (2027-2032) & (k pcs) Table 45. Global Favipiravir Tablets Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Favipiravir Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k pcs) Table 47. North America Favipiravir Tablets Sales by Country (2021-2026) & (k pcs) Table 48. North America Favipiravir Tablets Sales by Country (2027-2032) & (k pcs) Table 49. Europe Favipiravir Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k pcs) Table 50. Europe Favipiravir Tablets Sales by Country (2021-2026) & (k pcs) Table 51. Europe Favipiravir Tablets Sales by Country (2027-2032) & (k pcs) Table 52. Asia Pacific Favipiravir Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k pcs) Table 53. Asia Pacific Favipiravir Tablets Sales by Country (2021-2026) & (k pcs) Table 54. Asia Pacific Favipiravir Tablets Sales by Country (2027-2032) & (k pcs) Table 55. South America, Middle East and Africa Favipiravir Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k pcs) Table 56. South America, Middle East and Africa Favipiravir Tablets Sales by Country (2021-2026) & (k pcs) Table 57. South America, Middle East and Africa Favipiravir Tablets Sales by Country (2027-2032) & (k pcs) Table 58. Global Favipiravir Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Favipiravir Tablets Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Favipiravir Tablets Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Favipiravir Tablets Revenue Market Share by Region (2021-2026) Table 62. Global Favipiravir Tablets Revenue Market Share by Region (2027-2032) Table 63. Sun Pharma Company Information Table 64. Sun Pharma Business Overview Table 65. Sun Pharma Favipiravir Tablets Sales (k pcs), Price (USD/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Sun Pharma Favipiravir Tablets Product Portfolio Table 67. Sun Pharma Recent Development Table 68. Hisun Pharm Company Information Table 69. Hisun Pharm Business Overview Table 70. Hisun Pharm Favipiravir Tablets Sales (k pcs), Price (USD/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Hisun Pharm Favipiravir Tablets Product Portfolio Table 72. Hisun Pharm Recent Development Table 73. R-Pharma Company Information Table 74. R-Pharma Business Overview Table 75. R-Pharma Favipiravir Tablets Sales (k pcs), Price (USD/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. R-Pharma Favipiravir Tablets Product Portfolio Table 77. R-Pharma Recent Development Table 78. Lupin Company Information Table 79. Lupin Business Overview Table 80. Lupin Favipiravir Tablets Sales (k pcs), Price (USD/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Lupin Favipiravir Tablets Product Portfolio Table 82. Lupin Recent Development Table 83. Glenmark Company Information Table 84. Glenmark Business Overview Table 85. Glenmark Favipiravir Tablets Sales (k pcs), Price (USD/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Glenmark Favipiravir Tablets Product Portfolio Table 87. Glenmark Recent Development Table 88. Fujifilm Company Information Table 89. Fujifilm Business Overview Table 90. Fujifilm Favipiravir Tablets Sales (k pcs), Price (USD/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Fujifilm Favipiravir Tablets Product Portfolio Table 92. Fujifilm Recent Development Table 93. Dr. Reddy Company Information Table 94. Dr. Reddy Business Overview Table 95. Dr. Reddy Favipiravir Tablets Sales (k pcs), Price (USD/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Dr. Reddy Favipiravir Tablets Product Portfolio Table 97. Dr. Reddy Recent Development Table 98. Cipla Company Information Table 99. Cipla Business Overview Table 100. Cipla Favipiravir Tablets Sales (k pcs), Price (USD/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Cipla Favipiravir Tablets Product Portfolio Table 102. Cipla Recent Development Table 103. ChemRar Group Company Information Table 104. ChemRar Group Business Overview Table 105. ChemRar Group Favipiravir Tablets Sales (k pcs), Price (USD/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. ChemRar Group Favipiravir Tablets Product Portfolio Table 107. ChemRar Group Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Favipiravir Tablets Distributors List Table 111. Favipiravir Tablets Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Favipiravir Tablets Product Image Figure 2. Global Favipiravir Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Favipiravir Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Favipiravir Tablets Sales (2021-2032) & (k pcs) Figure 5. Global Favipiravir Tablets Average Price (USD/pcs) & (2021-2032) Figure 6. Global Top 5 and 10 Favipiravir Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Brand Drug Image Figure 9. Generic Drug Image Figure 10. Global Favipiravir Tablets Sales by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 11. Global Favipiravir Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Favipiravir Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Favipiravir Tablets Revenue by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 14. Global Favipiravir Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Favipiravir Tablets Revenue Market Share by Type (2021-2032) Figure 16. Influenza Viruses Image Figure 17. COVID-19 Image Figure 18. Others Image Figure 19. Global Favipiravir Tablets Sales by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 20. Global Favipiravir Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Favipiravir Tablets Sales Market Share by Application (2021-2032) Figure 22. Global Favipiravir Tablets Revenue by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 23. Global Favipiravir Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Favipiravir Tablets Revenue Market Share by Application (2021-2032) Figure 25. North America Favipiravir Tablets Sales and Growth Rate (2021-2032) & (k pcs) Figure 26. North America Favipiravir Tablets Sales Market Share by Country (2021-2032) Figure 27. U.S. Favipiravir Tablets Sales and Growth Rate (2021-2032) & (k pcs) Figure 28. Canada Favipiravir Tablets Sales and Growth Rate (2021-2032) & (k pcs) Figure 29. Mexico Favipiravir Tablets Sales and Growth Rate (2021-2032) & (k pcs) Figure 30. Europe Favipiravir Tablets Sales and Growth Rate (2021-2032) & (k pcs) Figure 31. Europe Favipiravir Tablets Sales Market Share by Country (2021-2032) Figure 32. Germany Favipiravir Tablets Sales and Growth Rate (2021-2032) & (k pcs) Figure 33. France Favipiravir Tablets Sales and Growth Rate (2021-2032) & (k pcs) Figure 34. U.K. Favipiravir Tablets Sales and Growth Rate (2021-2032) & (k pcs) Figure 35. Italy Favipiravir Tablets Sales and Growth Rate (2021-2032) & (k pcs) Figure 36. Netherlands Favipiravir Tablets Sales and Growth Rate (2021-2032) & (k pcs) Figure 37. Asia Pacific Favipiravir Tablets Sales and Growth Rate (2021-2032) & (k pcs) Figure 38. Asia Pacific Favipiravir Tablets Sales Market Share by Country (2021-2032) Figure 39. China Favipiravir Tablets Sales and Growth Rate (2021-2032) & (k pcs) Figure 40. Japan Favipiravir Tablets Sales and Growth Rate (2021-2032) & (k pcs) Figure 41. South Korea Favipiravir Tablets Sales and Growth Rate (2021-2032) & (k pcs) Figure 42. Southeast Asia Favipiravir Tablets Sales and Growth Rate (2021-2032) & (k pcs) Figure 43. India Favipiravir Tablets Sales and Growth Rate (2021-2032) & (k pcs) Figure 44. Australia Favipiravir Tablets Sales and Growth Rate (2021-2032) & (k pcs) Figure 45. South America, Middle East and Africa Favipiravir Tablets Sales and Growth Rate (2021-2032) & (k pcs) Figure 46. South America, Middle East and Africa Favipiravir Tablets Sales Market Share by Country (2021-2032) Figure 47. Brazil Favipiravir Tablets Sales and Growth Rate (2021-2032) & (k pcs) Figure 48. South Africa Favipiravir Tablets Sales and Growth Rate (2021-2032) & (k pcs) Figure 49. Saudi Arabia Favipiravir Tablets Sales and Growth Rate (2021-2032) & (k pcs) Figure 50. Turkey Favipiravir Tablets Sales and Growth Rate (2021-2032) & (k pcs) Figure 51. Argentina Favipiravir Tablets Sales and Growth Rate (2021-2032) & (k pcs) Figure 52. UAE Favipiravir Tablets Sales and Growth Rate (2021-2032) & (k pcs) Figure 53. Egypt Favipiravir Tablets Sales and Growth Rate (2021-2032) & (k pcs) Figure 54. Chile Favipiravir Tablets Sales and Growth Rate (2021-2032) & (k pcs) Figure 55. Global Favipiravir Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Favipiravir Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Favipiravir Tablets Revenue (2021-2032) & (US$ Million) Figure 58. North America Favipiravir Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Favipiravir Tablets Revenue (2021-2032) & (US$ Million) Figure 60. Europe Favipiravir Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Favipiravir Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Favipiravir Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Favipiravir Tablets Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Favipiravir Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Favipiravir Tablets Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Favipiravir Tablets Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Brand Drug
  • Generic Drug
Applications
  • Influenza Viruses
  • COVID-19
  • Others
Companies covered
  • Sun Pharma
  • Hisun Pharm
  • R-Pharma
  • Lupin
  • Glenmark
  • Fujifilm
  • Dr. Reddy
  • Cipla
  • ChemRar Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Favipiravir Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Favipiravir Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Favipiravir Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Favipiravir Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Favipiravir Tablets Market Dynamics
  1. 2.1 Favipiravir Tablets Industry Trends
  2. 2.2 Favipiravir Tablets Industry Drivers
  3. 2.3 Favipiravir Tablets Industry Opportunities and Challenges
  4. 2.4 Favipiravir Tablets Industry Restraints
3 Favipiravir Tablets Market by Manufacturers
  1. 3.1 Global Favipiravir Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Favipiravir Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Favipiravir Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Favipiravir Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Favipiravir Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Favipiravir Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Favipiravir Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Favipiravir Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Favipiravir Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Favipiravir Tablets Tier 1, Tier 2, and Tier 3
4 Favipiravir Tablets Market by Type
  1. 4.1 Favipiravir Tablets Type Introduction
  2. 4.1.1 Brand Drug
  3. 4.1.2 Generic Drug
  4. 4.2 Global Favipiravir Tablets Sales by Type
  5. 4.2.1 Global Favipiravir Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Favipiravir Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Favipiravir Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Favipiravir Tablets Revenue by Type
  9. 4.3.1 Global Favipiravir Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Favipiravir Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Favipiravir Tablets Revenue Market Share by Type (2021-2032)
5 Favipiravir Tablets Market by Application
  1. 5.1 Favipiravir Tablets Application Introduction
  2. 5.1.1 Influenza Viruses
  3. 5.1.2 COVID-19
  4. 5.1.3 Others
  5. 5.2 Global Favipiravir Tablets Sales by Application
  6. 5.2.1 Global Favipiravir Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Favipiravir Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Favipiravir Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Favipiravir Tablets Revenue by Application
  10. 5.3.1 Global Favipiravir Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Favipiravir Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Favipiravir Tablets Revenue Market Share by Application (2021-2032)
6 Global Favipiravir Tablets Sales by Region
  1. 6.1 Global Favipiravir Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Favipiravir Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Favipiravir Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Favipiravir Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Favipiravir Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Favipiravir Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Favipiravir Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Favipiravir Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Favipiravir Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Favipiravir Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Favipiravir Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Favipiravir Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Favipiravir Tablets Revenue by Region
  1. 7.1 Global Favipiravir Tablets Revenue by Region
  2. 7.1.1 Global Favipiravir Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Favipiravir Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Favipiravir Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Favipiravir Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Favipiravir Tablets Revenue (2021-2032)
  8. 7.2.2 North America Favipiravir Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Favipiravir Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Favipiravir Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Favipiravir Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Favipiravir Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Favipiravir Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Favipiravir Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sun Pharma
  2. 8.1.1 Sun Pharma Company Information
  3. 8.1.2 Sun Pharma Business Overview
  4. 8.1.3 Sun Pharma Favipiravir Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sun Pharma Favipiravir Tablets Product Portfolio
  6. 8.1.5 Sun Pharma Recent Developments
  7. 8.2 Hisun Pharm
  8. 8.2.1 Hisun Pharm Company Information
  9. 8.2.2 Hisun Pharm Business Overview
  10. 8.2.3 Hisun Pharm Favipiravir Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Hisun Pharm Favipiravir Tablets Product Portfolio
  12. 8.2.5 Hisun Pharm Recent Developments
  13. 8.3 R-Pharma
  14. 8.3.1 R-Pharma Company Information
  15. 8.3.2 R-Pharma Business Overview
  16. 8.3.3 R-Pharma Favipiravir Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 R-Pharma Favipiravir Tablets Product Portfolio
  18. 8.3.5 R-Pharma Recent Developments
  19. 8.4 Lupin
  20. 8.4.1 Lupin Company Information
  21. 8.4.2 Lupin Business Overview
  22. 8.4.3 Lupin Favipiravir Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Lupin Favipiravir Tablets Product Portfolio
  24. 8.4.5 Lupin Recent Developments
  25. 8.5 Glenmark
  26. 8.5.1 Glenmark Company Information
  27. 8.5.2 Glenmark Business Overview
  28. 8.5.3 Glenmark Favipiravir Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Glenmark Favipiravir Tablets Product Portfolio
  30. 8.5.5 Glenmark Recent Developments
  31. 8.6 Fujifilm
  32. 8.6.1 Fujifilm Company Information
  33. 8.6.2 Fujifilm Business Overview
  34. 8.6.3 Fujifilm Favipiravir Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Fujifilm Favipiravir Tablets Product Portfolio
  36. 8.6.5 Fujifilm Recent Developments
  37. 8.7 Dr. Reddy
  38. 8.7.1 Dr. Reddy Company Information
  39. 8.7.2 Dr. Reddy Business Overview
  40. 8.7.3 Dr. Reddy Favipiravir Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Dr. Reddy Favipiravir Tablets Product Portfolio
  42. 8.7.5 Dr. Reddy Recent Developments
  43. 8.8 Cipla
  44. 8.8.1 Cipla Company Information
  45. 8.8.2 Cipla Business Overview
  46. 8.8.3 Cipla Favipiravir Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Cipla Favipiravir Tablets Product Portfolio
  48. 8.8.5 Cipla Recent Developments
  49. 8.9 ChemRar Group
  50. 8.9.1 ChemRar Group Company Information
  51. 8.9.2 ChemRar Group Business Overview
  52. 8.9.3 ChemRar Group Favipiravir Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 ChemRar Group Favipiravir Tablets Product Portfolio
  54. 8.9.5 ChemRar Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Favipiravir Tablets Value Chain Analysis
  2. 9.1.1 Favipiravir Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Favipiravir Tablets Production Mode & Process
  6. 9.2 Favipiravir Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Favipiravir Tablets Distributors
  9. 9.2.3 Favipiravir Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst